While Recurrent Neural Networks (RNNs) are famously known to be Turing complete, this relies on infinite precision in the states and unbounded computation time. We consider the case of RNNs with finite precision whose computation time is linear in the input length. Under these limitations, we show that different RNN variants have different computational power. In particular, we show that the LSTM and the Elman-RNN with ReLU activation are strictly stronger than the RNN with a squashing activation and the GRU. This is achieved because LSTMs and ReLU-RNNs can easily implement counting behavior. We show empirically that the LSTM does indeed learn to effectively use the counting mechanism.
We develop a formal hierarchy of the expressive capacity of RNN architectures. The hierarchy is based on two formal properties: space complexity, which measures the RNN's memory, and rational recurrence, defined as whether the recurrent update can be described by a weighted finite-state machine. We place several RNN variants within this hierarchy. For example, we prove the LSTM is not rational, which formally separates it from the related QRNN (Bradbury et al., 2016). We also show how these models' expressive capacity is expanded by stacking multiple layers or composing them with different pooling functions. Our results build on the theory of "saturated" RNNs (Merrill, 2019). While formally extending these findings to unsaturated RNNs is left to future work, we hypothesize that the practical learnable capacity of unsaturated RNNs obeys a similar hierarchy. Experimental findings from training unsaturated networks on formal languages support this conjecture.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.